Type 2 diabetes

1. 1

   System

   the whole body at work

   • Normally, insulin binds its receptor on muscle, fat, and liver.
   • The receptor + GLUT4 + downstream signaling escort glucose into cells, shut down hepatic glucose production, and pull free fatty acids into storage.
   • Beta cells release insulin in two phases after a meal: a fast first phase, then a sustained second phase.
   • Result: post-meal glucose peaks ~140, drops to ~100 fasting.
2. 2

   Organ

   the healthy sequence, step by step

   • Insulin binds receptor → GLUT4 → glucose into muscle/fat
   • Insulin shuts off hepatic gluconeogenesis
   • Beta cells fire in two phases after a meal
   • Fasting glucose 70-99; post-meal peak ≤140
   • No osmotic diuresis, no microvascular injury
3. 3

   Tissue & mechanism

   where and why it breaks

   • It all starts with Chronic Fuel Overload.
   • You eat, your blood sugar rises, and the pancreas pumps out insulin—the key—to unlock the cell door.
   • But in Type 2, the cell door lock gets 'rusty' from constant use and inflammation; we call this insulin resistance.
   • Now, the pancreas has to scream louder (pump more insulin) just to get the same door to open.
   • Eventually, the pancreas gets tired and can't keep up, leaving glucose stuck in the pipes where it doesn't belong, causing a sticky, inflammatory mess in the vasculature.
4. 4

   Cell & molecule

   the break at its smallest scale

   • Chronic fuel intake leads to constant insulin signaling
   • Tissues become 'deaf' to insulin (Insulin Resistance)
   • The pancreas overcompensates with Hyperinsulinemia
   • Beta-cells burn out and glucose remains in the intravascular space
5. 5

   The result

   what the break produces

   • Tissues stop responding to insulin (insulin resistance)
   • Beta cells pump out more insulin to compensate
   • Eventually beta cells fatigue → relative insulin deficiency
   • Chronic hyperglycemia damages capillaries (retina, kidney, nerves)

• Normally, insulin binds its receptor on muscle, fat, and liver.
• The receptor + GLUT4 + downstream signaling escort glucose into cells, shut down hepatic glucose production, and pull free fatty acids into storage.
• Beta cells release insulin in two phases after a meal: a fast first phase, then a sustained second phase.
• Result: post-meal glucose peaks ~140, drops to ~100 fasting.

• It all starts with Chronic Fuel Overload.
• You eat, your blood sugar rises, and the pancreas pumps out insulin—the key—to unlock the cell door.
• But in Type 2, the cell door lock gets 'rusty' from constant use and inflammation; we call this insulin resistance.
• Now, the pancreas has to scream louder (pump more insulin) just to get the same door to open.
• Eventually, the pancreas gets tired and can't keep up, leaving glucose stuck in the pipes where it doesn't belong, causing a sticky, inflammatory mess in the vasculature.

• T2DM = insulin resistance + relative insulin deficiency.
• Muscle, fat, liver stop responding to insulin.
• Beta cells pump out more insulin to overcome the resistance — for years it works (compensated), then beta cells exhaust and glucose climbs.
• Chronic hyperglycemia + insulin signaling failure damage capillaries (retina, kidney, nerves) and accelerate macrovascular disease (MI, stroke, PAD).
• Each drug class hits one defect: insulin sensitivity, beta-cell support, glucose reabsorption, or GI release.

The chain that produces them

1. 1Beta cells pump out more insulin to compensate
2. 2Eventually beta cells fatigue → relative insulin deficiency
3. 3Chronic hyperglycemia damages capillaries (retina, kidney, nerves)
4. 4Accelerated macrovascular disease (MI, stroke, PAD)

• Labs diagnose, stage, and track complications.

Uncertainty: Individual glycemic targets must be personalized based on age, comorbidities, and hypoglycemia risk as determined by a clinician.